Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of trimetazidine in patients with angina pectoris after percutaneous coronary intervention
2010-022134-89Phase 3Terminated
- Sponsor
- I.R.I.S.
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in angina pectoris and coronary arteriosclerosis comparing Trimetazidine arm with Placebo arm (2 arms). Primary endpoint: Composite primary endpoint. Started Sep 2013; status: terminated.
02
Drugs
trimetazidine
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on 2010-022134-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022134-89.